http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. An atomic-level snapshot of a respiratory syncytial virus (RSV) protein bound to a human antibody represents a leap toward developing a vaccine for a common—and sometimes very serious—childhood disease. The findings, by scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, define the vulnerable shape of a critical RSV component called the fusion glycoprotein. http://medicalxpress.com/news/2013-04-clues-vaccine-infant-respiratory-illness.html Diseases, Conditions, Syndromes Thu, 25 Apr 2013 14:00:18 EST news286116578 The deadliest form of malaria is caused the protozoan Plasmodium falciparum. During its life-cycle in human blood, the parasite P. falciparum expresses unique proteins on the surface on infected blood cells. http://medicalxpress.com/news/2012-08-human-immunity-malaria.html Diseases, Conditions, Syndromes Wed, 01 Aug 2012 12:00:02 EST news263039631 (Phys.org) -- A group of scientists in Singapore and the UK have isolated a human antibody capable of effectively neutralizing the mosquito-borne dengue virus. Dengue fever is currently incurable and infects an estimated 100,000 people a year, mostly in the tropics. The only treatment is alleviating the symptoms, which can include intense joint and muscle pain, nausea, vomiting, high fever, and death in severe cases. http://medicalxpress.com/news/2012-06-human-antibody-dengue-virus-isolated.html Diseases, Conditions, Syndromes Fri, 22 Jun 2012 05:40:01 EST news259560458 Antibodies, once touted as the "magic bullets" of cancer care, are now fulfilling that promise and more advances are on the way, say cancer researchers at the Georgetown Lombardi Comprehensive Cancer Center http://medicalxpress.com/news/2012-03-bright-future-antibody-cancer-therapy.html Cancer Thu, 15 Mar 2012 12:00:01 EST news251031418 Some vaccines are once-in-a-lifetime; others need a booster shot or two to maintain their potency. And then there's the flu vaccine, which only lasts a year. Strains of influenza virus change so much from year-to-year that new vaccines must be developed annually to target the strains of virus that are most likely to cause illness. But Howard Hughes Medical Institute (HHMI) scientists have now discovered a human antibody that recognizes many different flu strains. Understanding more about this antibody may help scientists design a longer-lasting vaccine against the influenza virus. http://medicalxpress.com/news/2011-08-newly-antibody-strains-flu-virus.html Medical research Mon, 08 Aug 2011 15:10:05 EST news232030522 A paper published today in the scientific research journal Science, describes a novel, proprietary monoclonal antibody (FI6) discovered in a collaboration between Humabs BioMed SA, the Institute for Research in Biomedicine ("IRB") and the UK Medical Research Council (MRC). FI6 is the first neutralizing antibody that targets all 16 hemagglutinin subtypes of influenza A and represents an important development in the treatment of severe cases of flu, and in finding a universal flu vaccine. The paper also discusses Humabs' high throughput method of selecting rare antibodies from cultured plasma cells. http://medicalxpress.com/news/2011-07-humabs-antibody-neutralize-group-influenza.html Medical research Thu, 28 Jul 2011 14:05:29 EST news231080717